NCT00003125: Vaccine Therapy, Interleukin-2, and Sargramostim in Treating Patients With Advanced Tumors |
|
|
| Completed | 2 | 24 | US | ALVAC-CEA vaccine, aldesleukin, sargramostim, vaccinia-CEA vaccine | Georgetown University, National Cancer Institute (NCI) | Breast Cancer, Esophageal Cancer, Gastric Cancer, Lung Cancer, Pancreatic Cancer, Unspecified Adult Solid Tumor, Protocol Specific | 11/04 | 11/04 | | |
NCT00012246: Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal Tract |
|
|
| Terminated | 2 | 7 | US | carcinoembryonic antigen peptide 1-6D, incomplete Freund's adjuvant, sargramostim | The University of Texas Medical Branch, Galveston, National Cancer Institute (NCI) | Colorectal Cancer, Esophageal Cancer, Extrahepatic Bile Duct Cancer, Gallbladder Cancer, Gastric Cancer, Pancreatic Cancer, Small Intestine Cancer | 07/06 | 07/06 | | |
